Synaptogenix Inc (SNPX)

[InTheTrenches]

PRTA signs a licensing agreement with CELG for Tau preclinical drug candidate + other drug candidates:

http://ir.prothena.com/releasedetail.cfm?ReleaseID=1061508

- Prothena to receive a $100 million upfront payment and a $50 million equity investment by Celgene, with potential license payments and regulatory and commercial milestones, plus additional royalties on net sales from licensed programs
- Collaboration focuses on preclinical programs targeting proteins implicated in several neurodegenerative diseases, including tau, TDP-43 and an undisclosed third target

----------------------------

In spite of failures in Tau and A-Beta, companies are still willing to put up significant money for preclinical candidates in AD.

Can't wait to see what they will pay for a drug candidate ready for Phase 3. :)